Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 7, 2017
PARP inhibitor and chemotherapy combination trials for the treatment of advanced malignancies: does a development pathway forward exist?
U A Matulonis, B J Monk
American Journal of Hematology
|
April 1, 1994
Autologous peripheral stem cell transplantation of the blastic phase of chronic myeloid leukemia following sequential high-dose cytosine arabinoside and melphalan
U A Matulonis, J D Griffin, G P Canellos
Blood
|
May 1, 1995
Role of B7-1 in mediating an immune response to myeloid leukemia cells
U A Matulonis, C Dosiou, C Lamont, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 26, 2008
Long-term adjustment of early-stage ovarian cancer survivors
U A Matulonis, A Kornblith, H Lee, et al.
Gynecologic Oncology
|
August 7, 2004
Attitudes to chemotherapy in patients with ovarian cancer
R T Penson, F Dignan, M V Seiden, et al.
Cancer Chemotherapy and Pharmacology
|
January 29, 1999
Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer
K A Havlin, M J Ramirez, C M Legler, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 14, 2005
A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors
R T Penson, S M Campos, M V Seiden, et al.
Gynecologic Oncology
|
March 29, 2006
Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer
U A Matulonis, S Campos, L Duska, et al.
Gynecologic Oncology
|
May 2, 2001
The clinical utility of liposomal doxorubicin in recurrent ovarian cancer
S M Campos, R T Penson, A R Mays, et al.
Gynecologic Oncology
|
June 30, 2006
Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced müllerian malignancies: the modified triple doublet regimen
U A Matulonis, S Campos, C N Krasner, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 7, 2017
PARP inhibitor and chemotherapy combination trials for the treatment of advanced malignancies: does a development pathway forward exist?
U A Matulonis, B J Monk
American Journal of Hematology
|
April 1, 1994
Autologous peripheral stem cell transplantation of the blastic phase of chronic myeloid leukemia following sequential high-dose cytosine arabinoside and melphalan
U A Matulonis, J D Griffin, G P Canellos
Blood
|
May 1, 1995
Role of B7-1 in mediating an immune response to myeloid leukemia cells
U A Matulonis, C Dosiou, C Lamont, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 26, 2008
Long-term adjustment of early-stage ovarian cancer survivors
U A Matulonis, A Kornblith, H Lee, et al.
Gynecologic Oncology
|
August 7, 2004
Attitudes to chemotherapy in patients with ovarian cancer
R T Penson, F Dignan, M V Seiden, et al.
Cancer Chemotherapy and Pharmacology
|
January 29, 1999
Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer
K A Havlin, M J Ramirez, C M Legler, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 14, 2005
A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors
R T Penson, S M Campos, M V Seiden, et al.
Gynecologic Oncology
|
March 29, 2006
Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer
U A Matulonis, S Campos, L Duska, et al.
Gynecologic Oncology
|
May 2, 2001
The clinical utility of liposomal doxorubicin in recurrent ovarian cancer
S M Campos, R T Penson, A R Mays, et al.
Gynecologic Oncology
|
June 30, 2006
Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced müllerian malignancies: the modified triple doublet regimen
U A Matulonis, S Campos, C N Krasner, et al.
Page
of 3